Recent studies by the Marazzi group have reported that TOP1 inhibition protects against cell death induced by SARS-CoV-2 infection and suggested that TOP1 contributes to viral infection-induced pro-inflammatory responses (Rialdi et al., 2016; Ho et al., 2021). The gene discussed is TOP1; the disease is viral infectious disease.